About
Autolus is a clinical-stage, biopharmaceutical company, focused on the development and…
Activity
-
An incredible Wednesday evening of networking and scientific mixology hosted by Mills & Reeve and OUTbio. Great to connect with some familiar and…
An incredible Wednesday evening of networking and scientific mixology hosted by Mills & Reeve and OUTbio. Great to connect with some familiar and…
Liked by Chris Williams
-
I'm delighted to be speaking at Advanced Therapies Europe, September 2024. Register now to join me at the No.1 event for the Cell & Gene Therapy…
I'm delighted to be speaking at Advanced Therapies Europe, September 2024. Register now to join me at the No.1 event for the Cell & Gene Therapy…
Liked by Chris Williams
-
Our Head of Quality Control Rebecca Moore will be speaking at the 3rd Annual Cell Therapy Analytical Development Summit in London. Rebecca’s…
Our Head of Quality Control Rebecca Moore will be speaking at the 3rd Annual Cell Therapy Analytical Development Summit in London. Rebecca’s…
Liked by Chris Williams
Experience
Education
-
Imperial College London
-
Christopher M J Williams, Angelo G Scibetta, J Karsten Friedrich, Monica Canosa, Chiara Berlato, Charlotte H Moss, Helen C Hurst. AP-2γ promotes proliferation in breast tumour cells by direct repression of the CDKN1A gene (2009). EMBO Journal Vol 28 Issue 22 pp3591.
-
-
More activity by Chris
-
Looking forward to Advanded Therapies Europe Conference by Phacilitate next week. I shall be double dipping with an investor panel and by hosting a…
Looking forward to Advanded Therapies Europe Conference by Phacilitate next week. I shall be double dipping with an investor panel and by hosting a…
Liked by Chris Williams
-
I was delighted to share my thoughts in The Times about growing the UK’s innovation ecosystem, creating jobs growth and opportunities. I’m proud…
I was delighted to share my thoughts in The Times about growing the UK’s innovation ecosystem, creating jobs growth and opportunities. I’m proud…
Liked by Chris Williams
-
Had a blast this afternoon talking with Tony and Adam as we dove deep into Mazzella Companies' 70 year journey—sharing stories, family memories, and…
Had a blast this afternoon talking with Tony and Adam as we dove deep into Mazzella Companies' 70 year journey—sharing stories, family memories, and…
Liked by Chris Williams
-
I am incredibly proud to announce that we have been awarded a £1.6M project from Innovate UK’s Biomedical Catalyst 2023 Round 2: Industry-led R&D 🙌…
I am incredibly proud to announce that we have been awarded a £1.6M project from Innovate UK’s Biomedical Catalyst 2023 Round 2: Industry-led R&D 🙌…
Liked by Chris Williams
-
Today, the U.S. FDA approved our chemotherapy-free combination regimen of EGFR-targeting therapies for the first-line treatment of patients diagnosed…
Today, the U.S. FDA approved our chemotherapy-free combination regimen of EGFR-targeting therapies for the first-line treatment of patients diagnosed…
Liked by Chris Williams
-
A glove recycling initiative has been launched on Campus thanks to Xap Therapeutics' Katie Hall. As a member of the Campus Green Impact scheme…
A glove recycling initiative has been launched on Campus thanks to Xap Therapeutics' Katie Hall. As a member of the Campus Green Impact scheme…
Liked by Chris Williams
-
Glass half full, or half empty? I am for the former, and really excited to see the update below on how one-time therapies for sickle cell disease and…
Glass half full, or half empty? I am for the former, and really excited to see the update below on how one-time therapies for sickle cell disease and…
Liked by Chris Williams
-
Thank you to Alex Driggs and the team at Autolus Therapeutics for supporting my promotion whilst I juggle a 4-day week and young kids, to Justin Hope…
Thank you to Alex Driggs and the team at Autolus Therapeutics for supporting my promotion whilst I juggle a 4-day week and young kids, to Justin Hope…
Liked by Chris Williams
-
Announcing our Life Sciences Innovations (LSI) fund! It's been a fun journey with my partners and colleagues at TPG, and the truly talented…
Announcing our Life Sciences Innovations (LSI) fund! It's been a fun journey with my partners and colleagues at TPG, and the truly talented…
Liked by Chris Williams
Other similar profiles
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore MoreOthers named Chris Williams in United Kingdom
-
Chris Williams
-
Chris Williams
-
Chris Williams
-
Chris Williams
-
Chris Williams
Managing Director at ThirdRock - unlocking innovation reliefs to empower growth
2066 others named Chris Williams in United Kingdom are on LinkedIn
See others named Chris Williams